Displaying drugs 5001 - 5025 of 11848 in total
Retinamidic acid
Investigational
FG-2216
A orally active prolyl-hydroxylase inhibitor which can stabilize hypoxia-inducible transcription factor independent of oxygen availability.
Investigational
Matched Description: … A orally active prolyl-hydroxylase inhibitor which can stabilize hypoxia-inducible transcription factor …
Fluciclovine
Fluciclovine is under investigation in clinical trial NCT03036943 (Fluciclovine (18F) Imaging of Breast Cancer).
Investigational
N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate
Experimental
Matched Categories: … Compounds used in a research, industrial, or household setting …
Pegargiminase
Pegargiminase is an anticancer agent.
Investigational
Matched Categories: … Compounds used in a research, industrial, or household setting …
Thiacloprid
Experimental
Matched Categories: … Compounds used in a research, industrial, or household setting …
Indigo
Experimental
Investigational
Matched Categories: … Compounds used in a research, industrial, or household setting …
Oseltamivir acid
Experimental
Coprogen
Experimental
Comosain
Investigational
Porphobilinogen
Porphobilinogen is a pyrrole involved in porphyrin metabolism. It is generated by the enzyme ALA dehydratase, and converted into hydroxymethyl bilane by the enzyme porphobilinogen deaminase.
Experimental
Matched Description: … Porphobilinogen is a pyrrole involved in porphyrin metabolism. …
Lesogaberan
Lesogaberan has been used in trials studying the treatment and basic science of GERD, Reflux, Heartburn, Regurgitation, and Reflux Disease, among others.
Investigational
Matched Categories: … GABA-A Receptor Agonists …
Hydroxytyrosol
Hydroxytyrosol has been used in trials studying the prevention of Breast Cancer.
Investigational
Matched Categories: … Compounds used in a research, industrial, or household setting …
Peracetic acid
A liquid that functions as a strong oxidizing agent. It has an acrid odor and is used as a disinfectant.
Experimental
Matched Description: … A liquid that functions as a strong oxidizing agent. ... It has an acrid odor and is used as a disinfectant. …
Matched Categories: … Compounds used in a research, industrial, or household setting …
Matched Categories: … Compounds used in a research, industrial, or household setting …
L-Glycero-D-Manno-Heptopyranose
Experimental
Metribolone
A synthetic non-aromatizable androgen and anabolic steroid. It binds strongly to the androgen receptor and has therefore also been used as an affinity label for this receptor in the prostate and in prostatic tumors.
Experimental
Matched Iupac: … (1S,3aS,3bS,11aS)-1-hydroxy-1,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,11aH-cyclopenta[a]phenanthren …
Matched Description: … A synthetic non-aromatizable androgen and anabolic steroid. …
Matched Description: … A synthetic non-aromatizable androgen and anabolic steroid. …
17alpha-Estriol
Experimental
Matched Iupac: … (1S,2R,3aS,3bR,9bS,11aS)-11a-methyl-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H,11aH-cyclopenta[a]phenanthrene …
Sepranolone
Sepranolone has been investigated for the treatment of Premenstrual Dysphoric Disorder.
Investigational
Matched Iupac: … 1-[(1S,3aS,3bR,5aS,7S,9aS,9bS,11aS)-7-hydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren …
Pralnacasan
Pralnacasan is an orally bioavailable pro-drug of a potent, non-peptide inhibitor of interleukin-1beta converting enzyme (ICE).
Investigational
Matched Iupac: … N-[(4S,7S)-4-{[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]carbamoyl}-6,10-dioxo-octahydro-1H-pyridazino[1,2-a] …
Matched Description: … Pralnacasan is an orally bioavailable pro-drug of a potent, non-peptide inhibitor of interleukin-1beta …
Matched Description: … Pralnacasan is an orally bioavailable pro-drug of a potent, non-peptide inhibitor of interleukin-1beta …
Ginsenosides
Dammarane type triterpene saponins based mainly on the aglycones, protopanaxadiol and protopanaxatriol.
Experimental
Matched Iupac: … ,9aR,9bR)-1-(2-hydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-hexadecahydro-1H-cyclopenta[a] …
Aconiazide
Investigational
EDIT-301
EDIT-301 is an investigational cell therapy consisting of autologous CD34+ hematopoietic stem and progenitor cells edited by CRISPR/CAS12a at the gamma globin gene (HBG1 and HBG2).
Investigational
1,3-Thiazole-4-Carboxylic Acid
Experimental
Carbazochrome sulfonic acid
Experimental
Displaying drugs 5001 - 5025 of 11848 in total